conjugated microRNA-aptamer therapeutics (miRagen/Archemix)

N/A

Report date: 2025/05/14 13:51:57

Base Information

Drug Nameconjugated microRNA-aptamer therapeutics (miRagen/Archemix)

Drug Alias NameN/A

ClassificationCell and gene therapy > Gene therapy > mRNASmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide aptamerSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsCardiovascular Diseases

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesViridian Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesArchemix Corp Viridian Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsCardiovascular Diseases

Other Information

ATC CodeN/A